“ab fubinaca”的搜索结果

7 个项目

每页

设置升序顺序
  1. Cetaben

    Catalog No. A11137
    Quick View
    Peroxisome Proliferator
    Cetaben是一种独特的,不依赖PPARα的过氧化物酶体增殖物,具有降血脂活性,可抑制人肝癌Hep-G2细胞中的胆固醇合成,从而导致高尔基体形态发生可逆变化。 了解更多
  2. Choline Fenofibrate

    Catalog No. A15044
    Quick View
    CYP2C19/CYP2B6 抑制剂
    Choline Fenofibrate (ABT-335)是非诺贝特酸的胆碱盐,与瑞舒伐他汀联合用于治疗血脂异常。 了解更多
  3. BR102375

    Catalog No. A18849
    Quick View
    PPAR γ agonist
    BR102375 is a non-TZD peroxisome proliferator-activated receptor γ (PPAR γ) full agonist for the treatment of type 2 diabetes, reveals EC50 value of 0.28?μM and Amax ratio?of 98%. 了解更多
  4. VCE-004.8

    Catalog No. A18549
    Quick View
    PPARγ and CB2 receptor dual agonist
    VCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity. 了解更多
  5. MA-0204

    Catalog No. A19031
    Quick View
    PPARδ modulator
    MA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD). 了解更多
  6. Arhalofenate

    Catalog No. A21135
    Quick View
    PPARγ agonist
    Arhalofenate (MBX 102) is a selective partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ, used for the treatment of type 2 diabetes. 了解更多
  7. Indeglitazar

    Catalog No. A21148
    Quick View
    PPAR agonist
    Indeglitazar is an orally available peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma (γ). 了解更多

7 个项目

每页

设置升序顺序
Rewards